These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27566604)

  • 1. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
    Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
    Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
    Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma.
    Marrelli D; Roviello F; De Stefano A; Farnetani M; Garosi L; Messano A; Pinto E
    Oncology; 1999 Jul; 57(1):55-62. PubMed ID: 10394126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
    Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
    J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
    Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
    Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
    Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
    Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
    Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
    Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer.
    Marrelli D; Pinto E; De Stefano A; de Manzoni G; Farnetani M; Garosi L; Roviello F
    J Surg Oncol; 2001 Dec; 78(4):253-8. PubMed ID: 11745820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
    Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
    Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy.
    Choi SR; Jang JS; Lee JH; Roh MH; Kim MC; Lee WS; Qureshi W
    Dig Dis Sci; 2006 Nov; 51(11):2081-6. PubMed ID: 17009116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer.
    Moriyama J; Oshima Y; Nanami T; Suzuki T; Yajima S; Shiratori F; Funahashi K; Shimada H
    Surg Today; 2021 Oct; 51(10):1638-1648. PubMed ID: 33682011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.
    Li Y; Yang Y; Lu M; Shen L
    Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma.
    Qiu MZ; Lin JZ; Wang ZQ; Wang FH; Pan ZZ; Luo HY; Li YH; Zhou ZW; He YJ; Xu RH
    Int J Biol Markers; 2009; 24(4):258-64. PubMed ID: 20082274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
    Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer.
    Namikawa T; Kawanishi Y; Fujisawa K; Munekage E; Iwabu J; Munekage M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Today; 2018 Apr; 48(4):388-394. PubMed ID: 29043453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.